Prevention and Therapy of Metastatic HER-2(+) Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine

Ruzzi, F; Palladini, A; Clemmensen, S; Strobaek, A; Buijs, N; Domeyer, T; Dorosz, J; Soroka, V; Grzadziela, D; Rasmussen, CJ; Nielsen, IB; Soegaard, M; Semprini, MS; Scalambra, L; Angelicola, S; Landuzzi, L; Lollini, PL; Thorn, M

Lollini, PL (通讯作者),Univ Bologna, Alma Mater Inst Hlth Planet, I-40126 Bologna, Italy.;Lollini, PL (通讯作者),Univ Bologna, Dept Expt Diagnost & Specially Med DIMES, I-40126 Bologna, Italy.

BIOMEDICINES, 2022; 10 (10):

Abstract

Vaccines are a promising therapeutic alternative to monoclonal antibodies against HER-2(+) breast cancer. We present the preclinical activity of an ES......

Full Text Link